Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
NCT06921759· Phase 3· Eli Lilly and Company· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error